This intervention activated the IL-6/JAK/STAT3 signaling cascade, which recapitulates key pathological features of PCM—including significant upregulation of Bcl-2 expression in plasma cells that closely mirrors clinical observations in human patients (38). The gene discussed is IL6; the disease is paracoccidioidomycosis.